Prevention of sudden cardiac death in the young: Targeted evaluation of those at risk

Hellenic Journal of Cardiology

Volumn 47, Issue 5, 2006, Pages 251-254

  Anastasakis, Aris ^a   McKenna, William ^b   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Inherited cardiovascular diseases; Prevention; Sudden death; Young

Indexed keywords

ANTIARRHYTHMIC AGENT;

AUTOPSY; BRUGADA SYNDROME; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CONGESTIVE CARDIOMYOPATHY; EDITORIAL; FAMILY HEALTH; HEALTH HAZARD; HEALTH SURVEY; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MEDICAL ASSESSMENT; QT PROLONGATION; SUDDEN DEATH; ADULT; AGE;

ADULT; AGE FACTORS; ARRHYTHMIA; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; HUMANS;

EID: 35449000060     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Editorial

References (26)

1. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al: Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2001; 22: 1374-1450.
2. Karvouni E, Anastasakis A, Spiliopoulou C, et al: Sudden death in children and young adults: still cases of unknown cause. Eur Heart J, 2002 (abstract).
3. Behr E, Wood DA, Wright M, et al; Sudden Arrhythmic Death Syndrome Steering Group: Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet 2003; 362: 1457-1459.
4. Tan HL, Hofman N, van Langen IM, et al: Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005; 112: 207-213.
5. Anastasakis A, Theopistou A, Rigopoulos A, et al: Inherited cardiovascular diseases: Identification of silent/subclinical forms by screening target groups. J Am Coll Cardiol 2002; 39, issue 5, suppl A.
6. McKenna WJ, Oakley CM, Krikler DM, et al: Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985; 53: 412-416.
7. Kyriakides M, Triposkiades F, Anastasakis A, et al: Hypertrophic cardiomyopathy in Greece: clinical course and outcome. Chest 1998; 114: 1091-1096.
8. Corrado D, Pelliccia A, Bjornstad HH, et al; Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26: 516-524.
9. Maron BJ, McKenna WJ, Danielson GK, et al; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines: American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2003; 24: 1965-1991.
10. Anastasakis A, Kotta C, Kyriakogonas S, et al: Phenotype reveals genotype in a Greek long QT syndrome family. Europace 2006; 8: 241-244.
11. Miliou A, Anastasakis A, Leon G D'Cruz, et al: Low prevalence of cardiac troponin T mutations in a Greek hypertrophic cardiomyopathy cohort. Heart 2005; 91: 966-967.
12. Theopistou A, Anastasakis A, Miliou A, et al: Clinical features of hypertrophic cardiomyopathy caused by an Arg 278 Cys missense mutation in the cardiac troponin T gene. Am J Cardiol 2004; 94: 246-249.
13. Kaplan SR, Gard JJ, Protonotarios N, et al: Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm 2004; 1: 3-11.
14. Protonotarios N, Tsatsopoulou A, Anastasakis A, et al: Genotype-phenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin. J Am Coll Cardiol 2001; 38: 1477-1484.
15. Gatzoulis K, Protonotarios N, Anastasakis A, et al: Implantable defibrillator therapy in Naxos disease. Pacing Clin Electrophysiol 2000; 23: 1176-1178.
16. McKoy G, Protonotarios N, Crosby A, et al: Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000; 355: 2119-2124.
17. Basso C, Tsatsopoulou A, Thiene G, et al: "Petrified" right ventricle in long-standing Naxos arrhythmogenic right ventricular cardiomyopathy. Circulation 2001; 104: E132-133.
18. Corrado D, Fontaine G, Marcus FI, et al: Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. European Society of Cardiology and the Scientific Council on Cardiomyopathies of the World Heart Federation. J Cardiovasc Electrophysiol 2000; 11: 827-832.
19. Corrado D, Basso C, Schiavon M, et al: Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339: 364-369.
20. Basso C, Maron BJ, Corrado D, et al: Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 2000; 35: 1493-1501.
21. Hamid MS, Norman M, Quraishi A, et al: Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002; 40: 1445-1450.
22. Sen-Chowdhry S, Syrris P, McKenna WJ: Desmoplakin disease in arrhythmogenic right ventricular cardiomyopathy: early genotype-phenotype studies. Eur Heart J 2005; 26: 1582-1584.
23. McKenna WJ, Thiene G, Nava A, et al: Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994; 71: 215-218.
24. Antoniades L, Tsatsopoulou A, Anastasakis A, et al: Arrhythmogenic right ventricular cardiomyopathy/dysplasia caused by deletions in plakophilin2 and plakoglobin in families from Greece and Cyprus: Clinical disease expressivity, diagnosis and risk stratification. Eur Heart J 2006 in press.
25. Schwartz PJ, Priori SG, Spazzolini C, et al: Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103: 89-95.
26. Antzelevitch C, Brugada P, Borggrefe M, et al: Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005; 111: 659-670.